Compare TCRX & HOVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TCRX | HOVR |
|---|---|---|
| Founded | 2018 | 2013 |
| Country | United States | Canada |
| Employees | N/A | 30 |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 75.1M | 80.6M |
| IPO Year | 2021 | N/A |
| Metric | TCRX | HOVR |
|---|---|---|
| Price | $0.98 | $2.26 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | $7.00 | ★ $10.33 |
| AVG Volume (30 Days) | 580.7K | ★ 3.9M |
| Earning Date | 05-08-2026 | 04-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 12.28 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $10,325,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $19.81 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 266.65 | N/A |
| 52 Week Low | $0.88 | $0.92 |
| 52 Week High | $2.57 | $4.18 |
| Indicator | TCRX | HOVR |
|---|---|---|
| Relative Strength Index (RSI) | 40.60 | 45.76 |
| Support Level | $0.91 | $1.51 |
| Resistance Level | $1.16 | $2.63 |
| Average True Range (ATR) | 0.06 | 0.35 |
| MACD | -0.01 | -0.07 |
| Stochastic Oscillator | 21.57 | 11.08 |
TScan Therapeutics Inc is a fully integrated clinical-stage biotechnology company focused on developing a robust pipeline of T cell receptor (TCR)-engineered T cell, or TCR-T, therapies for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
New Horizon Aircraft Ltd is an aerospace Original Equipment Manufacturer that is designing and building a next-generation hybrid electric vertical take-off and landing aircraft for the regional air mobility market. Its aircraft will offer a more efficient way to move people and goods at a regional scale, help to connect remote communities, and advance its ability to deal with an increasing number of climate-related natural disasters such as wildfires, floods, and droughts. The company aims to deliver a hybrid electric 7-seat aircraft, called the Cavorite X7, that can take off and land vertically like and helicopter.